Although most older adults supported guidelines to discontinue colon cancer screening after age 75 years, a “sizable minority” did not, regardless of estimated life expectancy, according to a study published in JAMA Network Open. “Recent professional guidelines have sought to deimplement use of care that generally does not improve patient outcomes and involves unnecessary harms
The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with cardiometabolic syndrome at baseline, a speaker…
Durvalumab plus bevacizumab plus TACE has the potential to set a new standard of care. With additional follow-up of the EMERALD-1 study, future analyses, including…
TACE plus lenvatinib plus pembrolizumab showed significant, clinically meaningful improvement in progression-free survival in patients with unresectable, non-metastatic hepatocellular carcinoma compared with TACE plus placebo.…
Boerhaave syndrome, an effort rupture of the esophagus, is a rare but serious condition. Endoscopic vacuum therapy (EVT) is a new therapeutic approach for GI…
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with locally advanced or metastatic non-small…
The likelihood for obstructive sleep apnea went down by 74% among adults with optimal vs. insufficient healthy lifestyle behaviors, according to results published in BMC…
Patients with myelofibrosis who cleared driver mutations within 30 days after hematopoietic stem cell transplantation survived longer and exhibited reduce risk for relapse, according to…
Colonoscopies assisted by AI technology are significantly more likely to result in the resection of benign lesions only.
The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and Pfizer based on data that suggest…
